Results 171 to 180 of about 36,269 (231)

FGF1-FGFR2 axis regulated by nuclear receptor RORγ represents an effective strategy in intrahepatic cholangiocarcinoma. [PDF]

Cell Death Discov
Gu Z, Wang X, Wang H, Wang J, Huang Z, Pan D, Zhang Z, Zeng Y, Cai G, Sun H, Zheng J, Nie Y, Zhang Q, Li H, Chan FL, Wang J, Zheng J, Fan Y.   +17 more
europepmc   +1 more source

Harmonization trial of <i>FGFR1-3</i> testing strategies in cholangiocarcinoma patients: an Italian multicenter experience. [PDF]

Pathologica
Pepe F, Russo G, Scimone C, Palumbo L, Tommasi S, Pinto R, De Biase D, Maloberti T, Busico A, Santoro A, Salemi D, Melucci E, Cozzolino D, Toffolatti L, Bessi S, Sarracino C, Tomaiuolo I, Minucci A, Roscigno G, Esposito F, Pallante P, Lonardi S, Pruneri G, Troncone G, Fassan M, Malapelle U.   +25 more
europepmc   +1 more source

FGFR2 Gene Mutation Negative [PDF]

, 2020
openaire   +1 more source

Derazantinib enhances gemcitabine efficacy in PDAC by attenuating the NF-κB and MAPK pathways to suppress MUC5AC expression. [PDF]

Med Oncol
Ye W, Huang Y, Hong L, Ma Y, Huang J, Xu F, Han F, Qiu Y, Zou Z, Zhang Y, Li X.   +10 more
europepmc   +1 more source

Recent advances in molecular classification and multimodal treatment of intrahepatic cholangiocarcinoma. [PDF]

World J Surg Oncol
Saboor F, Lu J.
europepmc   +1 more source

FGFR2 Gene Rearrangement Negative [PDF]

, 2020
openaire   +1 more source

Unraveling the FGFR-RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose. [PDF]

Acta Pharm Sin B
Xian X, Gong R, Rong S, Zhang Z, Jia F, Li L, Chen Z, Eymin B, Jia T.   +8 more
europepmc   +1 more source

Anti-FGFR2 Antibody BAY1179470 [PDF]

, 2020
openaire   +1 more source

Diagnosing fetal apert syndrome: a case study on prenatal diagnosis and genetic insights. [PDF]

Quant Imaging Med Surg
Ge T, Zhang C, Qi J, Deng X, Du X, Wang Y, Tao J, Zou B, Lin X.   +8 more
europepmc   +1 more source

FGFR2 Gene Alteration Positive [PDF]

, 2020
openaire   +1 more source